Expandable metal stents in achalasia - Is there a role?

Sandeep Mukherjee, David S. Kaplan, Gulshan Parasher, Michael S. Sipple

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

OBJECTIVE: Achalasia is treated with pneumatic dilation or myotomy, and botulinum toxin injections are occasionally used. We review our community's experience with expandable metal stents in six patients who failed medical treatment or were poor surgical candidates. METHODS: Eight stents were placed in six patients between July 1995 and November 1997. Four patients had achalasia and two pseudoachalasia. Four patients underwent successive botulinum toxin injections. One patient only agreed to periodic Maloney dilatations or a stent. Pneumatic dilation was performed in one patient and considered high risk in the rest. All were poor surgical candidates. Three different stents were used: Gianturco Rosch Z stent, Wallstent I, and Wallstent II. RESULTS: One-month mortality and morbidity were 33% and 50%, respectively. Two patients were asymptomatic on a liquid diet for ≥6 months but required repeat endoscopy for recurrent dysphagia because of food bolus impaction and proximal stent migration in each. CONCLUSIONS: Expandable metal stents in achalasia or pseudoachalasia do not provide sustained symptom relief, and their use is associated with unacceptably high morbidity and mortality. We do not recommend the use of these devices in patients who have failed medical therapy or who are poor surgical candidates. (C) 2000 by Am. Coll. of Gastroenterology.

Original languageEnglish
Pages (from-to)2185-2188
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume95
Issue number9
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Esophageal Achalasia
Stents
Metals
Dilatation
Botulinum Toxins
Morbidity
Injections
Mortality
Gastroenterology
Deglutition Disorders
Endoscopy
Diet
Food
Equipment and Supplies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Expandable metal stents in achalasia - Is there a role? / Mukherjee, Sandeep; Kaplan, David S.; Parasher, Gulshan; Sipple, Michael S.

In: American Journal of Gastroenterology, Vol. 95, No. 9, 2000, p. 2185-2188.

Research output: Contribution to journalArticle

Mukherjee, Sandeep ; Kaplan, David S. ; Parasher, Gulshan ; Sipple, Michael S. / Expandable metal stents in achalasia - Is there a role?. In: American Journal of Gastroenterology. 2000 ; Vol. 95, No. 9. pp. 2185-2188.
@article{ee9b5b2549974765b85765959857b45c,
title = "Expandable metal stents in achalasia - Is there a role?",
abstract = "OBJECTIVE: Achalasia is treated with pneumatic dilation or myotomy, and botulinum toxin injections are occasionally used. We review our community's experience with expandable metal stents in six patients who failed medical treatment or were poor surgical candidates. METHODS: Eight stents were placed in six patients between July 1995 and November 1997. Four patients had achalasia and two pseudoachalasia. Four patients underwent successive botulinum toxin injections. One patient only agreed to periodic Maloney dilatations or a stent. Pneumatic dilation was performed in one patient and considered high risk in the rest. All were poor surgical candidates. Three different stents were used: Gianturco Rosch Z stent, Wallstent I, and Wallstent II. RESULTS: One-month mortality and morbidity were 33{\%} and 50{\%}, respectively. Two patients were asymptomatic on a liquid diet for ≥6 months but required repeat endoscopy for recurrent dysphagia because of food bolus impaction and proximal stent migration in each. CONCLUSIONS: Expandable metal stents in achalasia or pseudoachalasia do not provide sustained symptom relief, and their use is associated with unacceptably high morbidity and mortality. We do not recommend the use of these devices in patients who have failed medical therapy or who are poor surgical candidates. (C) 2000 by Am. Coll. of Gastroenterology.",
author = "Sandeep Mukherjee and Kaplan, {David S.} and Gulshan Parasher and Sipple, {Michael S.}",
year = "2000",
doi = "10.1016/S0002-9270(00)01093-5",
language = "English",
volume = "95",
pages = "2185--2188",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Expandable metal stents in achalasia - Is there a role?

AU - Mukherjee, Sandeep

AU - Kaplan, David S.

AU - Parasher, Gulshan

AU - Sipple, Michael S.

PY - 2000

Y1 - 2000

N2 - OBJECTIVE: Achalasia is treated with pneumatic dilation or myotomy, and botulinum toxin injections are occasionally used. We review our community's experience with expandable metal stents in six patients who failed medical treatment or were poor surgical candidates. METHODS: Eight stents were placed in six patients between July 1995 and November 1997. Four patients had achalasia and two pseudoachalasia. Four patients underwent successive botulinum toxin injections. One patient only agreed to periodic Maloney dilatations or a stent. Pneumatic dilation was performed in one patient and considered high risk in the rest. All were poor surgical candidates. Three different stents were used: Gianturco Rosch Z stent, Wallstent I, and Wallstent II. RESULTS: One-month mortality and morbidity were 33% and 50%, respectively. Two patients were asymptomatic on a liquid diet for ≥6 months but required repeat endoscopy for recurrent dysphagia because of food bolus impaction and proximal stent migration in each. CONCLUSIONS: Expandable metal stents in achalasia or pseudoachalasia do not provide sustained symptom relief, and their use is associated with unacceptably high morbidity and mortality. We do not recommend the use of these devices in patients who have failed medical therapy or who are poor surgical candidates. (C) 2000 by Am. Coll. of Gastroenterology.

AB - OBJECTIVE: Achalasia is treated with pneumatic dilation or myotomy, and botulinum toxin injections are occasionally used. We review our community's experience with expandable metal stents in six patients who failed medical treatment or were poor surgical candidates. METHODS: Eight stents were placed in six patients between July 1995 and November 1997. Four patients had achalasia and two pseudoachalasia. Four patients underwent successive botulinum toxin injections. One patient only agreed to periodic Maloney dilatations or a stent. Pneumatic dilation was performed in one patient and considered high risk in the rest. All were poor surgical candidates. Three different stents were used: Gianturco Rosch Z stent, Wallstent I, and Wallstent II. RESULTS: One-month mortality and morbidity were 33% and 50%, respectively. Two patients were asymptomatic on a liquid diet for ≥6 months but required repeat endoscopy for recurrent dysphagia because of food bolus impaction and proximal stent migration in each. CONCLUSIONS: Expandable metal stents in achalasia or pseudoachalasia do not provide sustained symptom relief, and their use is associated with unacceptably high morbidity and mortality. We do not recommend the use of these devices in patients who have failed medical therapy or who are poor surgical candidates. (C) 2000 by Am. Coll. of Gastroenterology.

UR - http://www.scopus.com/inward/record.url?scp=0033834638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033834638&partnerID=8YFLogxK

U2 - 10.1016/S0002-9270(00)01093-5

DO - 10.1016/S0002-9270(00)01093-5

M3 - Article

VL - 95

SP - 2185

EP - 2188

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 9

ER -